Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Marrow Aspirate ConCentrate for the Treatment of knEe Osteoarthritis: A Phase III, muLti-centER, Pan-cAnadian, prospecTivE Trial

NCT06216028 is registered in ClinicalTrials.gov with CELL Technologies Inc. as lead sponsor.

NCT NCT06216028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06216028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Marrow Aspirate ConCentrate for the Treatment of knEe Osteoarthritis: A Phase III, muLti-centER, Pan-cAnadian, prospecTivE Trial
Lead sponsor
CELL Technologies Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
December 31, 2026
Enrollment
374 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis, musculoskeletal diseases